Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Gene test may tailor chemo for pancreatic cancer patients

NCT ID NCT04683315

First seen Jan 11, 2026 · Last updated May 23, 2026 · Updated 17 times

Summary

This study tests whether a genetic test called PurIST can help doctors choose the best chemotherapy for people with pancreatic cancer that can be removed by surgery. About 84 participants will have their tumor's RNA analyzed to guide treatment. The goal is to see if this personalized approach leads to better tumor shrinkage before surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Froedtert & the Medical College of Wisconsin

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • HonorHealth Medical Group

    RECRUITING

    Scottsdale, Arizona, 85258-4566, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-••••

Conditions

Explore the condition pages connected to this study.